Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Galenica to commercialize Roche's Mircera in U.S.

May 29, 2015

Jinarc approved in Europe for autosomal dominant polycystic kidney disease

May 28, 2015

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

May 27, 2015

Daiichi Sankyo develops phosphate transporter inhibitors

May 22, 2015

Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder

May 18, 2015

Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function

May 18, 2015

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

May 8, 2015

Tenapanor fails to significantly reduce albuminuria in patients with CKD and type 2 diabetes

May 6, 2015

Recruitment initiated in phase II trial of CicloMulsion for acute kidney injury

April 28, 2015

Merck & Co. presents novel MR antagonists

April 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...